1-12859056-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_023014.1(PRAMEF2):āc.47G>Cā(p.Ser16Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000511 in 1,604,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_023014.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRAMEF2 | NM_023014.1 | c.47G>C | p.Ser16Thr | missense_variant | 2/4 | ENST00000240189.2 | NP_075390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRAMEF2 | ENST00000240189.2 | c.47G>C | p.Ser16Thr | missense_variant | 2/4 | 1 | NM_023014.1 | ENSP00000240189 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 43AN: 148922Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000641 AC: 16AN: 249586Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135040
GnomAD4 exome AF: 0.0000268 AC: 39AN: 1454984Hom.: 0 Cov.: 33 AF XY: 0.0000180 AC XY: 13AN XY: 723814
GnomAD4 genome AF: 0.000289 AC: 43AN: 149026Hom.: 0 Cov.: 31 AF XY: 0.000220 AC XY: 16AN XY: 72652
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | The c.47G>C (p.S16T) alteration is located in exon 2 (coding exon 1) of the PRAMEF2 gene. This alteration results from a G to C substitution at nucleotide position 47, causing the serine (S) at amino acid position 16 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at